Clinical Trial Update: Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SharkCore EUS-guided biopsy needle versus ProCore has been withdrawn. Sponsor: Johns Hopkins University; conditions listed include auto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Pancreatitis
• Lymphoma
• Mesenchymal Tumor
• Solid Tumors

Snippet

Sponsor: Johns Hopkins University | Conditions: Mesenchymal Tumor, Autoimmune Pancreatitis | Phase 2 | Status: WITHDRAWN